<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of thyroid nodule formation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of thyroid nodule formation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of thyroid nodule formation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas S Ross, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David S Cooper, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jean E Mulder, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 01, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         This topic will review the prevalence, risk factors, risk of cancer, and etiology of thyroid nodules. An understanding of these factors is essential in developing a reasonable diagnostic approach to patients with these thyroid nodules. (See
         <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">
          "Diagnostic approach to and treatment of thyroid nodules"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nodularity of thyroid tissue is extremely common. In a large population study (Framingham, MA), as an example, clinically apparent thyroid nodules were present in 6.4 percent of women and 1.5 percent of men [
         <a href="#rid1">
          1
         </a>
         ]. These figures significantly underestimate the true frequency of this disorder, as evidenced by the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In surveys of unselected subjects using ultrasonography, 20 to 76 percent of women had at least one thyroid nodule [
         <a href="#rid2">
          2,3
         </a>
         ]. In Germany, an area of relative iodine deficiency, 96,278 screening ultrasounds found thyroid nodules or goiter in 33 percent of men and 32 percent of women; nodules over 1 cm were found in 11.9 percent of the population [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of nodular goiter increased with age from 2.7 and 2.0 percent in women and men aged 26 to 30 years, to 8.7 and 6.7 percent in women and men aged 36 to 40 years, to 14.1 and 12.4 percent in women and men aged 45 to 50 years, and to 18.0 and 14.5 percent in women and men over age 55 years [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In several autopsy surveys, 37 to 57 percent of patients had thyroid nodules [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with a single palpable nodule, from 20 to 48 percent had additional nodules as detected by ultrasonography [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Thus, while many nodules are detected because of their size or anterior position in the neck, or the skill of the clinician performing the examination, most thyroid nodules are not clinically recognized.
        </p>
        <p class="headingAnchor" id="H44876647">
         <span class="h1">
          CAUSES AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major causes of benign and malignant thyroid nodules are listed in the table  (
         <a class="graphic graphic_table graphicRef57701" href="/z/d/graphic/57701.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased risk
         </strong>
         – Factors associated with an increased risk of thyroid nodules and goiter include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Smoking, especially in areas of mild iodine deficiency [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Obesity and metabolic syndrome have been associated with thyroid nodules in observational studies [
         <a href="#rid9">
          9,10
         </a>
         ], but assessment by Mendelian randomization does not suggest a causal relationship except in those with a high genetic susceptibility for type 2 diabetes [
         <a href="#rid11">
          11
         </a>
         ]. Obesity is also associated with higher TSH values, thought to be mediated by higher leptin levels. Thus, both insulin resistance with hyperinsulinemia, and higher TSH values, may be contributing to the association of obesity with goiter [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alcohol consumption is associated with thyroid enlargement, more so in women [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Insulin-like growth factor 1 (IGF-1) levels – Associated with nodules in men and goiter in both men and women [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Uterine fibroids – In one report, women with fibroids had a twofold-increased risk of thyroid nodules compared with women with a normal uterus [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Decreased risk
         </strong>
         – Factors associated with a possible decreased risk include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oral contraceptive use [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use of statins (associated with a reduced risk of nodules on ultrasound) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          RATE OF CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unless thyroid nodules, single or multiple, cause obstruction or are cosmetically disturbing, their mass alone does not cause trouble. The main concerns then are: (1) whether or not they are cancers or, if they are, whether they are lethal, and (2) whether or not they cause thyroid dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">
          "Diagnostic approach to and treatment of thyroid nodules"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7873.html" rel="external">
          "Treatment of toxic adenoma and toxic multinodular goiter"
         </a>
         .)
        </p>
        <p>
         Most thyroid nodules are benign. Surgical series suggesting that 20 to 40 percent of thyroid nodules are cancers all had significant selection bias. Two reports probably provide a more accurate estimate of the true frequency of thyroid cancer among patients with thyroid nodules:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a community hospital in North Carolina where most patients with nodules were referred for surgery without benefit of biopsy, 6.5 percent of excised nodules were cancers [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In Catania, Italy, 2327 patients presenting with nodules were evaluated by fine-needle aspiration (FNA) biopsy, and 391 were selected for surgery [
         <a href="#rid19">
          19
         </a>
         ]. Cancers were found in 28 percent of the surgical specimens, which represented only 5 percent of all nodules.
        </p>
        <p>
        </p>
        <p>
         However, in Boston, among patients referred to a thyroid practice, the rate of malignancy in thyroid nodules was 14 percent [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Differentiated thyroid cancers (papillary and follicular), which account for approximately 90 percent of all thyroid cancers, usually have a good prognosis [
         <a href="#rid21">
          21
         </a>
         ]. This is particularly true in younger patients; as an example, the long-term (25-year) mortality of patients under age 40 years with papillary cancers was less than 2 percent after primary surgical therapy [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         The frequency of occult papillary thyroid microcarcinomas (less than 1 cm in size) is much higher. In the United States, as an example, 6 to 13 percent of all thyroid glands studied at autopsy contain a papillary microcarcinoma [
         <a href="#rid23">
          23,24
         </a>
         ]. The prevalence is substantially higher in some other countries, reaching 36 percent in Finland [
         <a href="#rid25">
          25
         </a>
         ]. Thus, microcarcinomas are common and are little threat to life.
        </p>
        <p>
         However, the natural history of microcarcinomas is uncertain. Approximately 15 percent of all differentiated thyroid cancers may behave in an aggressive manner [
         <a href="#rid21">
          21
         </a>
         ]. They can metastasize and, in older patients who present with a cancer that invades through the thyroid capsule, the long-term mortality is 35 to 65 percent [
         <a href="#rid22">
          22,26
         </a>
         ]. Anaplastic carcinomas, some medullary cancers, and thyroid lymphomas are also associated with higher mortality but are encountered less commonly than differentiated thyroid cancer [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Risk factors for cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several risk factors for the development of thyroid cancer have been identified in non-iodine-deficient populations, including age, sex, and history of thyroid irradiation.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thyroid nodularity increases with age [
         <a href="#rid6">
          6
         </a>
         ]. The presence of a thyroid nodule in a child is twice more likely to be a cancer than if it was in an adult [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among patients with thyroid nodules, the rate of cancer is twice as high in men than women (8 versus 4 percent), and it is higher in adults over age 60 and under age 30 years than in those aged 30 to 60 years [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A history of radiation treatment to the head and neck region to treat acne, inflammation of the tonsils or adenoids, or thymic enlargement is associated with an increased incidence of thyroid nodularity and cancer [
         <a href="#rid28">
          28
         </a>
         ]. In two large series, 20 to 27 percent of patients had thyroid nodularity and 30 to 33 percent of the nodules were cancers; however, some were microcarcinomas [
         <a href="#rid29">
          29,30
         </a>
         ]. There is no evidence that radiation-associated thyroid cancers are more aggressive than other thyroid cancers [
         <a href="#rid28">
          28,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hematopoietic stem cell transplantation increases the relative risk (RR) for thyroid cancer to 3.26; if transplantation occurred prior to age 10, the RR was 24.6 [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H346970383">
         <span class="h2">
          Size
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thyroid cancer appears to be more common in nodules ≥2 cm compared with &lt;2 cm [
         <a href="#rid33">
          33
         </a>
         ]. In one study of 4955 patients, the risk of malignancy in nodules 1.0 to 1.9 cm was 10.5 percent, while the risk in nodules 2.0 to 2.9, 3.0 to 3.9, or greater than 4 cm was 14, 16, and 15 percent, respectively [
         <a href="#rid34">
          34
         </a>
         ]. While larger nodule size over 2 cm was not associated with an increased risk of malignancy, the proportion of papillary cancers reduced from 92 to 74 percent, while the proportion of follicular cancers increased from 6 to 16 percent as nodules increased from under 2 to over 4 cm.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          ETIOLOGY OF NODULE FORMATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The possible role of oncogenes and tumor suppressor genes in the pathogenesis of these lesions is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7819.html" rel="external">
          "Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Macrofollicular nodules
         </span>
         <span class="headingEndMark">
          —
         </span>
         Benign macrofollicular thyroid nodules represent two distinct processes: true monoclonal adenomas [
         <a href="#rid35">
          35
         </a>
         ] and colloid nodules in a multinodular goiter. Most of the latter nodules are also monoclonal [
         <a href="#rid36">
          36,37
         </a>
         ]; they represent the expansion of relatively clonogenic cells, which replicate in nodular fashion. Both polyclonal and monoclonal nodules appear similar on fine-needle aspiration (FNA; macrofollicular) and are benign [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Follicular neoplasms (microfollicular adenomas)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Follicular neoplasms (microfollicular or cellular "adenomas") represent a unique diagnostic problem. They differ from follicular carcinomas only by their lack of capsular or vascular invasion [
         <a href="#rid38">
          38,39
         </a>
         ]. Thus, the diagnosis of follicular cancer in situ does not exist, because vascular or capsular invasion is required to make the diagnosis of follicular cancer. Until recently, most microfollicular lesions were excised to exclude cancer, unless they were shown to have autonomous function demonstrated by thyroid scintigraphy. FNA biopsy of autonomous nodules may demonstrate a microfollicular pattern, but these nodules are virtually always benign [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7890.html" rel="external">
          "Diagnostic approach to and treatment of thyroid nodules", section on 'Thyroid scintigraphy'
         </a>
         .)
        </p>
        <p>
         Molecular markers, either an mRNA gene expression classifier or mutational analysis, have been used to triage follicular neoplasms for excision versus observation. The use of molecular markers in the evaluation of follicular neoplasms is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/116428.html" rel="external">
          "Evaluation and management of thyroid nodules with indeterminate cytology in adults", section on 'Molecular markers'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Multinodular goiters
         </span>
         <span class="headingEndMark">
          —
         </span>
         The process of goitrogenesis is distinct from true neoplasia [
         <a href="#rid36">
          36,38,39,41
         </a>
         ]. It was, therefore, assumed that multinodular goiters were unlikely to contain a cancer. Several studies have suggested that the frequency of cancer in nodular goiters is approximately 25 to 60 percent of that in solitary nodules [
         <a href="#rid42">
          42-44
         </a>
         ].
        </p>
        <p>
         However, a retrospective study of patients with multinodular goiter with one or more dominant nodules who underwent ultrasound-guided FNA biopsy found that 5 percent had thyroid cancers, which is the frequency in patients with solitary nodules [
         <a href="#rid45">
          45
         </a>
         ]. In another study, the risk of malignancy was similar in a patient with a single or multiple nodules, but the risk of malignancy was higher in a solitary nodule than in a non-solitary nodule [
         <a href="#rid20">
          20
         </a>
         ]. Thus, despite the tendency to preferentially biopsy the dominant nodule in a multinodular goiter, in one study, half of the cancers in a multinodular goiter were in non-dominant nodules [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15901.html" rel="external">
          "Patient education: Thyroid nodules (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/17222.html" rel="external">
          "Patient education: Nodular goiter (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2162.html" rel="external">
          "Patient education: Thyroid nodules (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5375075">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Nodular thyroid tissue is extremely common. In one study, clinically apparent thyroid nodules were present in 6.4 percent of women and 1.5 percent of men. However, in surveys of unselected subjects using ultrasonography, 20 to 76 percent of women had at least one thyroid nodule. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Major causes of benign thyroid nodules
         </strong>
         – The major causes of benign thyroid nodules are multinodular goiter, Hashimoto's thyroiditis, and follicular adenomas  (
         <a class="graphic graphic_table graphicRef57701" href="/z/d/graphic/57701.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Causes and risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rate of cancer
         </strong>
         – Most thyroid nodules are benign. Thyroid cancer occurs in 5 to 15 percent of thyroid nodules. The incidence depends in part upon age, sex, radiation exposure, and family history. (See
         <a class="local">
          'Rate of cancer'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154:1838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiners C, Wegscheider K, Schicha H, et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14:926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice, CO. Incidence of nodules in the thyroid. Arch Surg 1932; 24:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MORTENSEN JD, WOOLNER LB, BENNETT WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955; 15:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knudsen N, Bülow I, Laurberg P, et al. Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med 2002; 162:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sousa PA, Vaisman M, Carneiro JR, et al. Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metabol 2013; 57:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin J, Kim MH, Yoon KH, et al. Relationship between metabolic syndrome and thyroid nodules in healthy Koreans. Korean J Intern Med 2016; 31:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fussey JM, Beaumont RN, Wood AR, et al. Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study. J Clin Endocrinol Metab 2020; 105:e2398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yildirim Simsir I, Cetinkalp S, Kabalak T. Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma. Med Princ Pract 2020; 29:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valeix P, Faure P, Bertrais S, et al. Effects of light to moderate alcohol consumption on thyroid volume and thyroid function. Clin Endocrinol (Oxf) 2008; 68:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Völzke H, Friedrich N, Schipf S, et al. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab 2007; 92:4039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spinos N, Terzis G, Crysanthopoulou A, et al. Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids. Thyroid 2007; 17:1257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knudsen N, Bülow I, Laurberg P, et al. Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol (Oxf) 2002; 57:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cappelli C, Castellano M, Pirola I, et al. Reduced thyroid volume and nodularity in dyslipidaemic patients on statin treatment. Clin Endocrinol (Oxf) 2008; 68:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Werk EE Jr, Vernon BM, Gonzalez JJ, et al. Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 1984; 144:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 1989; 121:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006; 91:3411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sisson JC. Medical treatment of benign and malignant thyroid tumors. Endocrinol Metab Clin North Am 1989; 18:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102:1088.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 1974; 34:2072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludwig, G, Nishiyama, RH. The prevalence of occult papillary thyroid cancer in 100 consecutive autopsies in an American population. Lab Invest 1976; 34:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985; 56:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider AB, Shore-Freedman E, Ryo UY, et al. Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies. Medicine (Baltimore) 1985; 64:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Favus MJ, Schneider AB, Stachura ME, et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med 1976; 294:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cerletty JM, Guansing AR, Engbring NH, et al. Radiation-related thyroid carcinoma. Arch Surg 1978; 113:1072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acharya S, Sarafoglou K, LaQuaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003; 97:2397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen A, Rovelli A, Merlo DF, et al. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007; 25:2449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin JJ, Caragacianu D, Randolph GW. Impact of thyroid nodule size on prevalence and post-test probability of malignancy: a systematic review. Laryngoscope 2015; 125:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamran SC, Marqusee E, Kim MI, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab 2013; 98:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aeschimann S, Kopp PA, Kimura ET, et al. Morphological and functional polymorphism within clonal thyroid nodules. J Clin Endocrinol Metab 1993; 77:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramelli F, Studer H, Bruggisser D. Pathogenesis of thyroid nodules in multinodular goiter. Am J Pathol 1982; 109:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apel RL, Ezzat S, Bapat BV, et al. Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 1995; 4:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RL, Wahner HW, Gorman CA. Rectilinear thyroid scanning as a predictor of malignancy. Ann Intern Med 1978; 88:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas GA, Williams D, Williams ED. The clonal origin of thyroid nodules and adenomas. Am J Pathol 1989; 134:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           CERISE EJ, RANDALL S, OCHSNER A. Carcinoma of the thyroid and nontoxic nodular goiter. Surgery 1952; 31:552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCall A, Jarosz H, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 1986; 100:1128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franklyn JA, Daykin J, Young J, et al. Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 1993; 307:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tollin SR, Mery GM, Jelveh N, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 2000; 10:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yong JS, Loh KS, Petersson BF, Thong M. Multinodular goiter: A study of malignancy risk in nondominant nodules. Ear Nose Throat J 2017; 96:336.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7863 Version 14.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5673172" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8053752" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Thyroid incidentalomas. Prevalence by palpation and ultrasonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1947082" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Thyroid gland: US screening in a random adult population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15671771" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Incidence of nodules in the thyroid
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13263417" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Gross and microscopic findings in clinically normal thyroid glands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9027275" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11863477" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Association of tobacco smoking with goiter in a low-iodine-intake area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23525289" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prevalence of goiter and thyroid nodular disease in patients with class III obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26767863" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Relationship between metabolic syndrome and thyroid nodules in healthy Koreans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32392279" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31542786" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18031329" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Effects of light to moderate alcohol consumption on thyroid volume and thyroid function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17666480" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17988198" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12100072" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17666091" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Reduced thyroid volume and nodularity in dyslipidaemic patients on statin treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6703815" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cancer in thyroid nodules. A community hospital survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2773619" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : High frequency of cancer in cold thyroid nodules occurring at young age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16835280" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2663479" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Medical treatment of benign and malignant thyroid tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3686348" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4474057" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The prevalence of occult papillary thyroid cancer in 100 consecutive autopsies in an American population
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2408737" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3194846" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : An expanded view of risk-group definition in differentiated thyroid carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1415299" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3965855" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1256510" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/687105" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Radiation-related thyroid carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12733137" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17557958" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24965892" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Impact of thyroid nodule size on prevalence and post-test probability of malignancy: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23275525" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Thyroid nodule size and prediction of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8370709" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Morphological and functional polymorphism within clonal thyroid nodules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7137321" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Pathogenesis of thyroid nodules in multinodular goiter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7551291" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Clonality of thyroid nodules in sporadic goiter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8426623" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Management of a solitary thyroid nodule.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8420446" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Fine-needle aspiration biopsy of the thyroid: an appraisal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/619756" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Rectilinear thyroid scanning as a predictor of malignancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2913822" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : The clonal origin of thyroid nodules and adenomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14922102" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Carcinoma of the thyroid and nontoxic nodular goiter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3787469" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8369686" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10779138" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28846789" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Multinodular goiter: A study of malignancy risk in nondominant nodules.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
